In summary, our study demonstrates that our HNSCC mouse model is valuable for developing novel cancer therapeutic approaches [31], and that IL-13-PE has therapeutic potential to treat human head and neck cancer. The gene discussed is IL13; the disease is head and neck squamous cell carcinoma.